Search

Your search keyword '"Sereno A"' showing total 707 results

Search Constraints

Start Over You searched for: Author "Sereno A" Remove constraint Author: "Sereno A" Publisher elsevier bv Remove constraint Publisher: elsevier bv
707 results on '"Sereno A"'

Search Results

6. Residual Lung Abnormality Following COVID-19 Hospitalisation is Characterised by Epithelial Injury

8. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

9. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

10. P1.21-07 Quantitative Assessment of OX40L and Its Association with Sensitivity to First-Line Pembrolizumab in Non-small-Cell Lung Cancer

12. EP11.03-13 Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study

15. Long COVID research: an update from the PHOSP-COVID Scientific Summit

18. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

19. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

25. Physical and Mental Health Effects of Long Covid in People with Diabetes 12 Months after Hospitalisation in the UK: A Prospective Cohort Study

30. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

36. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

39. Mitochondrial and redox modifications in early stages of Huntington's disease

41. Sustaining communicable disease elimination efforts in the Americas in the wake of COVID-19

43. Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment

45. Defining milestones for the study of remyelination using the cuprizone mouse model: How early is early?

48. Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth impairment

49. Altered visual population receptive fields in human albinism

Catalog

Books, media, physical & digital resources